Manufacturer
Regeneron Pharmaceuticals
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 10
- Molecules
- 7
- Therapy areas
- 2
Regeneron Pharmaceuticals is a pharmaceutical manufacturer based in United States. MedsAcross lists 10 of its products across 7 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Regeneron Pharmaceuticals, Inc, Regeneron Pharmaceuticals, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Regeneron Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Oncology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Eylea 2 mg/0.05 mL injectionIntravitreal | Aflibercept | US FDA | Available on request |
| Eylea HD 8 mg/0.07 mL injectionIntravitreal | Aflibercept | US FDA | Available on request |
| Libtayo 350 mg/7 mL injectionIntravenous Cold chain | Cemiplimab | US FDA | Available on request |
Cardiology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Praluent 150 mg/1 mL injectionSubcutaneous Cold chain | Alirocumab | US FDA | Available on request |
| Praluent 75 mg/1 mL injectionSubcutaneous Cold chain | Alirocumab | US FDA | Available on request |
Other products
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Inmazeb 241.7 mg/241.7 mg/241.7 mg per 14.5 mL injectionIntravenous Cold chain | Atoltivimab, Maftivimab and Odesivimab | US FDA | Available on request |
| Inmazeb 483.3 mg/483.3 mg/483.3 mg per 14.5 mL injectionIntravenous Cold chain | Atoltivimab, Maftivimab and Odesivimab | US FDA | Available on request |
| Otarmeni 30000000000000 GC/mL injectionIntracochlear Cold chain | Lunsotogene parvec | US FDA | Available on request |
| Pasatru 300 mg/5 mL injectionIntravenous Cold chain | Garetosmab | US FDA | Available on request |
| Veopoz 400 mg/2 mL injectionIntravenous, subcutaneous Cold chain | Pozelimab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Regeneron Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.